Efforts to control sexually transmitted infections as a means to limit HIV transmission: What is the evidence?
- 31 Downloads
There is overwhelming and compelling evidence that control efforts for sexually transmitted infection (STI) have a major role to play in the prevention of HIV transmission. Community-based randomized controlled trials are set as the highest standard of evidence for showing the efficacy of STI interventions to prevent HIV transmission. The negative results of recent randomized controlled trials have cast doubt on the positive findings of the Mwanza study. Deeper analysis of the result of these trials has improved understanding of the role of STI interventions and augmented the wealth of evidence provided by numerous epidemiologic and biomedical studies. Apart from the biologic impact of effective treatment of curable STIs on HIV transmission, clinical services also support the reduction of HIV risk behaviors. STI interventions should limit the scale of the impending epidemics in Asia and Eastern Europe, depending on the priority that they are given by governments and major donor agencies.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.UNAIDS report: most deaths and new infections ever; some good news. AIDS Treat News 2003, (396)3.Google Scholar
- 3.Baeten JM, Mostad SB, Hughes MP, et al.: Selenium deficiency is associated with shedding of HIV-1 infected cells in the female genital tract. J Acquir Immune Defic Syn 2001, 26:360–364.Google Scholar
- 5.Koopman JS, Jacquez JA, Welch GW, et al.: The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syn 1997, 14:56–62.Google Scholar
- 12.UNAIDS/WHO: Consultation on STD Interventions for Preventing HIV: What is the evidence? UNAIDS, Geneva, Switzerland, May 2000.Google Scholar
- 25.Buchacz K, Patel P, Taylor M, et al.: Syphilis infection increases HIV viral load in HIV-infected men. Paper presented at the National HIV Prevention Conference. Atlanta, Georgia, July 27–30, 2003.Google Scholar
- 28.Coombs RW, Reichelderfer PS, Landay AL: Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003, 17:455–480. Comprehensive review of virologic, microbiologic, and immunologic parameters that affect HIV-1 pathogenesis and sexual transmission.PubMedCrossRefGoogle Scholar
- 31.Reynolds SJ, Risbud AR, Shepherd ME, et al.: Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003, 187:1513–1521. Large retrospective cohort study in India correlating timing of HSV-2 seroconversion to HIV-1 acquisition.PubMedCrossRefGoogle Scholar
- 33.The HIV Trials Prevention Network: HPTN 039 A Phase III, randomized, double-blind, placebo-controlled trial of acyclovir for the reduction of HIV acquisition among high risk HSV-2 seropositive, HIV-seronegative individuals. http:// www.hptn.org/research_studies/hptn039.asp.Accessed January 8,2004.Google Scholar
- 34.The Bill & Melinda Gates Foundation: Gates Foundation provides $30 million grant for first-ever study of Herpes treatment to reduce HIV transmission. http://www.gatesfoundation. org/GlobalHealth/HIVAIDSTB/HIVAIDS/Announcements/ Announce-030724.htm.Accessed April 18, 2004.Google Scholar
- 39.Gray RH, Wawer MJ, Sewankambo NK, et al.: Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. AIDS 1999, 13:2113–2123.PubMedCrossRefGoogle Scholar
- 40.Kamali A, Quigley M, Nakiyingi J, et al.: Syndromic management of sexually-transmitted infections and behavior change interventions on transmission of HIV-1 in rural Uganda: a community randomized trial. Lancet 2003, 361:645–652. Report of a three-arm community randomized trial of HIV education, HIV education and syndromic STI management, and community development to assess impact on HIV-1 transmission.PubMedCrossRefGoogle Scholar
- 44.Orroth KK, Korenromp EL, White RG, et al.: Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes. AIDS 2003, 17:2653–2660. In-depth reanalysis of baseline data from three trial populations comparing sexual demography, sexual risk behavior, and HIV/STI epidemiology adjusting for underlying performance characteristics of STIdiagnostic tests.PubMedCrossRefGoogle Scholar
- 45.Orroth K, White RG, Bakker R, et al.: Proportion of HIV infection attributable to sexually transmitted disease in Mwanza and Rakai -results of a simulation model. Paper presented at the 2003 International Society for Sexually Transmitted Disease Research Congress. Ottawa, Canada, July 27–30, 2003.Google Scholar
- 47.Kaul R, Kimani J, Nagelkerke NJ, et al.: Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infection and HIV1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004, 291:2555–2562. Report of a double-blind, placebo-controlled trial of STI treatment in sex workers in Kenya assessing the impact on STI and HIV incidence.PubMedCrossRefGoogle Scholar
- 50.Monitoring the AIDS Pandemic report: AIDS in Asia: face the facts - a comprehensive analysis of the AIDS epidemics in Asia. Monitoring the AIDS Pandemic report. 2004. http:// www.mapnetwork.org/reports/aids_in_asia.html). Accessed April 18, 2004.Google Scholar